80 to 84-year-olds invited for vaccination sooner Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.
Nationwide assessment of SARS-CoV-2 laboratories: very high quality The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.
Number of COVID-19 infections continues to increase 1,329 new COVID-19 infections were reported over the past week. That is 342 more confirmed cases reported than the week before that, when 987 new COVID-19 infections were reported.
Number of COVID-19 infections is increasing 987 new COVID-19 infections were reported over the past week. This is nearly twice the number of infections reported in the previous week, when 534 new cases were reported.
Gap between intention and behaviour in staying home and testing for COVID-19 The Dutch policy of staying home and getting tested if you have corona-related symptoms can count on support from the majority of the over 50,000 participants in RIVM’s behavioural study.
About 100 COVID-19 infections detected per week through source and contact tracing The results of 14 days of monitoring of source and contact tracing are known for week 26 (22 to 28 June).
Nanotechnology in the fight against cancer Nanotechnology offers improved options for the diagnosis and treatment of cancer.
Tracking down sources of disease outbreaks like Sherlock Holmes. 'I want to know the story behind an epidemic'. Interview with Jaap van Dissel, Director of RIVM Centre for Infectious Disease Control.